191 related articles for article (PubMed ID: 33692637)
1. First-Line Antiretroviral Regimen Failure and Determinants in an Urban HIV Clinic at Phramongkutklao Hospital, Bangkok, Thailand: 20 Years Experience.
Nasomsong W; Phokaphol K; Changpradub D
HIV AIDS (Auckl); 2021; 13():261-269. PubMed ID: 33692637
[TBL] [Abstract][Full Text] [Related]
2. The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso.
Penot P; Héma A; Bado G; Kaboré F; Soré I; Sombié D; Traoré JR; Guiard-Schmid JB; Fontanet A; Slama L; Bruno Sawadogo A; Laurent C
J Int AIDS Soc; 2014; 17(1):18646. PubMed ID: 24433983
[TBL] [Abstract][Full Text] [Related]
3. Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria.
Ndembi N; Murtala-Ibrahim F; Tola M; Jumare J; Aliyu A; Alabi P; Mensah C; Abimiku A; Quiñones-Mateu ME; Crowell TA; Rhee SY; Shafer RW; Gupta R; Blattner W; Charurat ME; Dakum P
AIDS Res Ther; 2020 Nov; 17(1):64. PubMed ID: 33143751
[TBL] [Abstract][Full Text] [Related]
4. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
Chang LW; Harris J; Humphreys E
Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
[TBL] [Abstract][Full Text] [Related]
5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
6. Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa.
Fox MP; Sanne IM; Conradie F; Zeinecker J; Orrell C; Ive P; Rassool M; Dehlinger M; van der Horst C; McIntyre J; Wood R
AIDS; 2010 Aug; 24(13):2041-50. PubMed ID: 20613459
[TBL] [Abstract][Full Text] [Related]
7. Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997-2011.
Martin DA; Luz PM; Lake JE; Clark JL; Veloso VG; Moreira RI; Cardoso SW; Klausner JD; Grinsztejn B
BMC Infect Dis; 2014 Jun; 14():322. PubMed ID: 24919778
[TBL] [Abstract][Full Text] [Related]
8. Determinants of virologic failure among adult HIV patients on first line antiretroviral treatment in Oromia, Central Ethiopia: 2022 a case-control study.
Ayana WG; Ayana Hordofa M; Dechasa Yadeta A
AIDS Res Ther; 2024 Jun; 21(1):42. PubMed ID: 38915090
[TBL] [Abstract][Full Text] [Related]
9. Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy.
Suaysod R; Ngo-Giang-Huong N; Salvadori N; Cressey TR; Kanjanavanit S; Techakunakorn P; Krikajornkitti S; Srirojana S; Laomanit L; Chalermpantmetagul S; Lallemant M; Le Cœur S; McIntosh K; Traisathit P; Jourdain G
Clin Infect Dis; 2015 Jul; 61(1):95-101. PubMed ID: 25838288
[TBL] [Abstract][Full Text] [Related]
10. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with first-line antiretroviral treatment failure in adult HIV-positive patients: a case-control study from Ethiopia.
Bezabih YM; Beyene F; Bezabhe WM
BMC Infect Dis; 2019 Jun; 19(1):537. PubMed ID: 31215397
[TBL] [Abstract][Full Text] [Related]
12. Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam.
Cuong DD; Sönnerborg A; Van Tam V; El-Khatib Z; Santacatterina M; Marrone G; Chuc NT; Diwan V; Thorson A; Le NK; An PN; Larsson M
BMC Infect Dis; 2016 Dec; 16(1):759. PubMed ID: 27986077
[TBL] [Abstract][Full Text] [Related]
13. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
Siegfried N; Uthman OA; Rutherford GW
Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens.
Zheng Y; Hughes MD; Lockman S; Benson CA; Hosseinipour MC; Campbell TB; Gulick RM; Daar ES; Sax PE; Riddler SA; Haubrich R; Salata RA; Currier JS
Clin Infect Dis; 2014 Sep; 59(6):888-96. PubMed ID: 24842909
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm
Han WM; Ubolyam S; Apornpong T; Kerr SJ; Hansasuta P; Gatechompol S; Maekanantawat W; Ruxrungtham K; Phanuphak P; Ananworanich J; Avihingsanon A
J Virus Erad; 2020 Sep; 6(3):100005. PubMed ID: 33251023
[TBL] [Abstract][Full Text] [Related]
16. Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China.
Wu G; Zhou C; Zhang X; Zhang W; Lu R; Ouyang L; Xing H; Shao Y; Ruan Y; Qian HZ
AIDS Res Hum Retroviruses; 2019; 35(11-12):1095-1102. PubMed ID: 31544479
[TBL] [Abstract][Full Text] [Related]
17. Predictors of virologic failure in HIV-1-infected patients starting highly active antiretroviral therapy in Porto Alegre, Brazil.
Tuboi SH; Harrison LH; Sprinz E; Albernaz RK; Schechter M
J Acquir Immune Defic Syndr; 2005 Nov; 40(3):324-8. PubMed ID: 16249707
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.
Ongubo DM; Lim R; Tweya H; Stanley CC; Tembo P; Broadhurst R; Gugsa S; Ngongondo M; Speight C; Heller T; Phiri S; Hosseinipour MC
BMC Infect Dis; 2017 Jul; 17(1):461. PubMed ID: 28673254
[TBL] [Abstract][Full Text] [Related]
19. First-line antiretroviral therapy durability in a 10-year cohort of naïve adults started on treatment in Uganda.
Castelnuovo B; Kiragga A; Mubiru F; Kambugu A; Kamya M; Reynolds SJ
J Int AIDS Soc; 2016; 19(1):20773. PubMed ID: 27319742
[TBL] [Abstract][Full Text] [Related]
20. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.
Bisson GP; Gross R; Bellamy S; Chittams J; Hislop M; Regensberg L; Frank I; Maartens G; Nachega JB
PLoS Med; 2008 May; 5(5):e109. PubMed ID: 18494555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
